CryoLife Announces First Clinical Use of BioFoam(R)
(Reuters )
BioFoam is based on the same protein hydrogel technology platform from which BioGlue Surgical Adhesive was developed. BioFoam received CE mark approval for … | See original press release
—
The use of BioFoam for liver resection represents a strong trend toward the expanded use of sealants and glues for internal applications, even if only used adjunctively with other closure.
See the MedMarket Diligence report #S175 on "Worldwide Surgical Sealants, Glues and Wound Closure, 2009-2013".
Posted via email from medmarket’s posterous
bookmark to
CryoLife Announces First Clinical Use of BioFoam(R)
Post a Comment